Intracellular concentrations of enrofloxacin in quinolone-resistant Salmonella enterica subspecies enterica serovar Choleraesuis

International Journal of Antimicrobial Agents

Volumn 34, Issue 6, 2009, Pages 592-595

  Usui, Masaru ^a   Uchiyama, Mariko ^a   Iwanaka, Mari ^a   Nagai, Hidetaka ^a   Yamamoto, Yoshimi ^b   Asai, Tetsuo ^a  

^a NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Antibiotic accumulation; Quinolones; Resistance; Salmonella Choleraesuis

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; ENROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTERIUM MUTANT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG IDENTIFICATION; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA; SEROTYPE; SUBSPECIES;

ANIMALS; ANTI-BACTERIAL AGENTS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CYTOSOL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS, ANIMAL; SWINE DISEASES; UNCOUPLING AGENTS;

EID: 70350409704     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.07.009     Document Type: Article

References (15)

1. Chiu C.H., Su L.H., and Chu C. Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev 17 (2004) 311-322
2. Hohmann E.L. Nontyphoidal salmonellosis. Clin Infect Dis 32 (2001) 263-269
3. Esaki H., Chiu C.H., Kojima A., Ishihara K., Asai T., Tamura Y., et al. Comparison of fluoroquinolone resistance genes of Salmonella enterica serovar Choleraesuis isolates in Japan and Taiwan. Jpn J Infect Dis 57 (2004) 287-288
4. Hopkins K.L., Davies R.H., and Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25 (2005) 358-373
5. Jacoby G.A. Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl. 2 (2005) S120-S126
6. Yamane K., Wachino J., Suzuki S., Kimura K., Shibata N., Kato H., et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51 (2007) 3354-3360
7. Ricci V., Tzakas P., Buckley A., and Piddock L.J. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 50 (2006) 38-42
8. Asai T, Namimatsu T, Osumi T, Kojima A, Harada K, Aoki H, et al. Molecular typing and antimicrobial resistance of Salmonella enterica subspecies enterica serovar Choleraesuis isolates from diseased pigs in Japan. Comp Immunol Microbiol Infect Dis 2008, in press.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. 2nd ed. Document M31-A2. Wayne, PA: NCCLS; 2002.
10. Giraud E., Brisabois A., Martel J.L., and Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43 (1999) 2131-2137
11. Piddock L.J., Jin Y.F., Ricci V., and Asuquo A.E. Quinolone accumulation by Pseudomonas aeruginosa. Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother 43 (1999) 61-70
12. Schnaitman C.A. Solubilization of the cytoplasmic membrane of Escherichia coli by Triton X-100. J Bacteriol 108 (1971) 545-552
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
14. Chapman J.S., and Georgopapadakou N.H. Routes of quinolone permeation in Escherichia coli. Antimicrob Agents Chemother 32 (1988) 438-442
15. Hirai K., Aoyama H., Irikura T., Iyobe S., and Mitsuhashi S. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. J Antimicrob Chemother 29 (1986) 353-358